NCATS Offering Principles of Preclinical Translation Science Class

Enhance your translational science skills this fall with a seven-week online course designed by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

The course, MEDI 501: Principles of Preclinical Translational Science, is offered by NCATS in partnership with the Foundation for Advanced Education in the Sciences (FAES), which is located at the NIH. 

In this course, students will learn preclinical translational science principles. Faculty will teach these principles through a case study of a highly successful translational research partnership involving NCATS, the National Cancer Institute, Northwestern University and the University of Kansas. The partnership produced a promising potential drug shown to inhibit cancer metastasis in animal models and that is being examined in a first-in-human clinical trial in 2020.

 The course is relevant to individuals in a range of roles — including scientists, administrators and specialists in scientific collaboration — and is appropriate across all career stages, from students to senior scientists.

This one-credit course requires a time commitment of about one hour per week to listen to course lectures, plus time to complete course readings and other short assignments. 

To learn more, please go to, where you’ll be able to view the course syllabus and speakers, as well as a course flyer with more information.

Registration is now open.

If you are new to FAES, you will need to create a new account. There is a short wait time after submitting the form while FAES reviews the information submitted. After this review, the account will be activated and the prospective student will receive an email with the subject heading “Welcome to FAES”, and will be able to register for MEDI501.

Please contact Lameese Akacem, PhD ( or Jessica Faupel-Badger, PhD, MPH ( at the NCATS Education Branch with any questions about the format or content of the course.

Stay Connected

Join the ACCEL newsletter and keep up to date with the latest news, events and funding opportunities!